NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HUMAN IMMUNOME PROJECT INC, founded in 2014, is a community nonprofit in the Medical Research sector that reported $1.8M in total revenue in fiscal year 2024. Revenue fell 41% from the prior year — a significant decline worth monitoring. Expenses of $2.3M exceeded revenue, resulting in a 28% operating deficit.
TO DECODE THE HUMAN IMMUNE SYSTEM TO ACCELERATE VACCINE AND THERAPEUTIC DEVELOPMENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,774,377 | $3,031,421 | -0.4% |
| Expenses | $2,264,932 | $3,193,387 | -0.3% |
| Net Income | $-490,555 | $-161,966 | +2.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HANS KEIRSTEAD | BOARD MEMBER/CEO | 20.00 |
Officer
Director
|
$156,000 | $0 | $156,000 |
| JANE METCALFE | BOARD CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOSE-MARIA FERNANDEZ | BOARD MEMBER/FINANCE AUDIT & RISK | 2.00 |
Director
|
$0 | $0 | $0 |
| DOUGLAS RICHMAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KENNETH HOLROYD | BOARD MEMBER/FINANCE AUDIT & RISK | 1.00 |
Director
|
$0 | $0 | $0 |
| REY RAMSEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LINDA AVEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| NEEMA MGANA | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT KLEIN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE WOEHRLE | DIRECTOR OF OPERATIONS | 40.00 |
Director
|
$232,826 | $0 | $232,826 |
| MICHELLE BAIR | VP, PHILANTHROPY & ADMIN | 40.00 |
Director
|
$102,458 | $0 | $102,458 |
| LIZA KANE-HARTNETT | COMMUNICATIONS DIRECTOR | 40.00 |
Director
|
$157,617 | $0 | $157,617 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,774,377 | $2,264,932 | $1,745,859 | $-490,555 |
| 2023 | $3,031,421 | $3,193,387 | $2,899,822 | $-161,966 |
| 2022 | $3,415,032 | $2,830,434 | $3,061,987 | $584,598 |
| 2020 | $2,277,458 | $3,442,083 | $2,187,885 | $-1,164,625 |
| 2019 | $4,374,412 | $5,691,231 | $3,549,964 | $-1,316,819 |
| 2018 | $5,216,398 | $5,510,677 | $4,378,616 | $-294,279 |
Compare HUMAN IMMUNOME PROJECT INC with other nonprofits in New York and across the country.